Life Sciences Tools and Services
Company Overview of Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation engages in immune-based discoveries and diagnostics by developing sequencing assays for research and drug development needs. It offers an immunoSEQ hsTCRB kit and analyzer to profile T-cell and B-cell receptor genes. The company provides tools and services for researchers and clinicians (at academic centers and biopharmaceutical companies) to diagnose, treat, and monitor patients with cancers, minimal residual diseases, autoimmune disorders, infectious diseases, and other immune-mediated diseases via its proprietary immune profiling sequencing technology. It serves customers worldwide. Adaptive Biotechnologies Corporation was formerly known as Adaptive TC...
1551 Eastlake Avenue East
Seattle, WA 98102
Founded in 2009
Key Executives for Adaptive Biotechnologies Corporation
Founder, Chief Executive Officer, President and Director
Chief Financial Officer, Director and Chairman of Audit Committee
Senior Vice President of Operations
Compensation as of Fiscal Year 2015.
Adaptive Biotechnologies Corporation Key Developments
Adaptive Biotechnologies Replaces Dean Schorno with Chad Cohen as Chief Financial Officer
Aug 10 15
Adaptive Biotechnologies announced the appointment of Chad Cohen as its new Chief Financial Officer, effective immediately. Most recently, Mr. Cohen served as CFO for Zillow Group, where he oversaw all finance, treasury and accounting functions and led the finance organization through Zillow's 2011 IPO and nine acquisitions. Dean Schorno, the company’s preceding CFO, will step down to pursue a local opportunity in the San Francisco Bay Area where he resides.
Adaptive Biotechnologies Corporation Presents at UBS Genomics 2.0 Summit, Aug-13-2015 08:00 AM
Aug 10 15
Adaptive Biotechnologies Corporation Presents at UBS Genomics 2.0 Summit, Aug-13-2015 08:00 AM. Venue: The St. Regis Deer Valley, Park City, Utah, United States. Speakers: Chad Robins, Founder, Chief Executive Officer, President and Director.
Adaptive Biotechnologies Corporation Presents at Sachs Immuno-Oncology: BD&L and Investment Forum, May-29-2015 09:50 AM
May 17 15
Adaptive Biotechnologies Corporation Presents at Sachs Immuno-Oncology: BD&L and Investment Forum, May-29-2015 09:50 AM. Venue: Hyatt Chicago Magnificent Mile, Chicago, Illinois, United States. Speakers: Sharon Benzeno, Senior Director, New Product Development.
Similar Private Companies By Industry
Recent Private Companies Transactions
May 5, 2015
January 7, 2015
January 7, 2015